Video Shorts

1:27
What Does the Future Look Like for RAS-Targeted Therapies in Pancreatic Cancer?
a month ago
by
Daniel King, MD, PhD

1:33
Highlighting the Efficacy of Tucatinib Plus Trastuzumab and Pertuzumab in HER2+ Breast Cancer
a month ago
by
Erika P. Hamilton, MD

1:26
Maurie Markman, MD, Talks AI in Cancer Care
a month ago
by
Maurie Markman, MD

0:31
Unpacking FIT-001 Data in RCC
a month ago
by
Adanma Ayanambakkam, MD, MS

0:30
Highlighting the Importance of Proactive Breast Cancer Care
a month ago
by
Eleonora Teplinsky, MD(+1 more)

1:24
Golcadomide Plus Rituximab Drives Durable Responses in R/R Follicular Lymphoma
a month ago
by
Daniel Morillo, MD

1:40
Can AI Help Cure Cancer?
a month ago
by
Maurie Markman, MD

0:40
Why the TKI May Stay On at Next Line in EGFR-Mutated NSCLC
a month ago
by
Millie Das, MD

0:40
Joshua Richter, MD, Answers Rahul Banerjee, MD, FACP
a month ago
by
Joshua Richter, MD

0:51
KRASCENDO 170 Data With Divarasib and Pembrolizumab in Lung Cancer
a month ago
by
Ferdinandos Skoulidis, MD, PhD, MRCP

0:35
Joshua Richter, MD, Discusses Multiple Myeloma Vaccines
a month ago
by
Joshua Richter, MD, Tisch Cancer Center at Mount Sinai

1:18
Phase 1 Efficacy Data With INCB161734 in Pancreatic Cancer
a month ago
by
Brandon Huffman, MD

0:48
Investigating Golcadomide in R/R Follicular Lymphoma
a month ago
by
Daniel Morillo, MD

0:28
Has Balazs Halmos, MD, ever met his celebrity look alike?
a month ago
by
Balazs Halmos, MD, MS

0:47
Spotlighting the lidERA Trial in Breast Cancer
a month ago
by
Ajaz M. Khan, MD, MBA, CPE

2:03
Exploring the Use of Proton Therapy in Head and Neck Cancer
a month ago
by
Madhur Garg, MD, MBA, FACR

1:58
Highlighting Potential Future Updates to the HER2+ Breast Cancer Treatment Paradigm
a month ago
by
Alessandro A. Viansone, MD

1:15
Where Iberdomide Plus Daratumumab and Dexamethasone Fits in the R/R Myeloma Paradigm
a month ago
by
Rahul Banerjee, MD

1:46
Exploring Atebimetinib in Metastatic Pancreatic Cancer
a month ago
by
Meredith Pelster, MD, MSCI

0:31
Managing Sacituzumab Govitecan–Related AEs in Breast Cancer
a month ago
by
Nan Chen, MD

0:54
Dry Eye vs ADC-Related AEs in Breast Cancer
a month ago
by
Sara Nunnery, MD, MSCI(+1 more)

0:44
PFS Data With TUB-040 in Platinum-Resistant Ovarian Cancer
a month ago
by
Toon Van Gorp, MD, PhD

0:41
One Second-line Therapy Trial Still Needed in HCC
a month ago
by
Erman Akkus, MD

1:18
The Implications of Biomarker Analyses With Sacituzumab Govitecan in TNBC
a month ago
by
Sara M. Tolaney, MD, MPH

1:03
Exploring Real-World Dose Reductions of RET Inhibitors in RET+ NSCLC
a month ago
by
William Phillips, MD

1:15
Updated Efficacy Findings With Abemaciclib and Hormonal Therapy in Gynecologic Cancers
a month ago
by
Jordyn Silverstein, MD

1:13
Navigating Molecular Testing in Multiple Myeloma
a month ago
by
Rafael Fonseca, MD

1:20
Exploring the Potential Role of CD24 in Lung Cancer
a month ago
by
Daniel Boiarsky, MD

0:59
The Role of Optometry Referrals in the Breast Cancer ADC Treatment Plan
a month ago
by
Sara Nunnery, MD, MSCI(+1 more)

1:01
Public Libraries as a Resource for Cancer Information
a month ago
by
Maurie Markman, MD
Advertisement
Advertisement
Trending on OncLive
1
ASCO Issues First Living Guideline for Systemic Treatment of Recurrent Ovarian Cancer
2
OSE2101 Plus Pembrolizumab as Maintenance Boosts PFS in Platinum-Sensitive Ovarian Cancer
3
FDA Approves Imlunestrant Plus Abemaciclib for ER+, HER2–, ESR1-Mutated Metastatic Breast Cancer
4
The OncFive: Top Oncology Articles for the Week of 9/14/2026
5
